AbbVie Common Stock (ABBV)
226.92
-0.67%
AbbVie Common Stock (ABBV) is currently trading at $226.92. This represents a loss of 0.67% from the previous session. With a market capitalization of $402.63B, ABBV is a key component of the Health Care sector. Investors looking to trade ABBV should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade ABBV commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, AbbVie Common Stock (ABBV) shows a bearish trend. Analysts are watching the 232.55 level closely.
Fundamentals
Mkt Cap402.63B
P/E Ratio0.0000
Volume5,384,070
60-Day Technical Chart
Advanced Charting
Need more indicators for ABBV? Use the world's #1 platform.
Open ABBV on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $227
| Metric |
ABBV -0.67% |
AMD -1.39% |
AMZN +1.00% |
FSLR -13.61% |
|---|---|---|---|---|
| Price | $226.92 | $210.86 | $210.64 | $210.12 |
| Mkt Cap | $402.63B | $344.29B | $2,258.73B | $22.55B |
| - | View → | View → | View → |
Latest Headlines
AbbVie (ABBV) Stock: What RBC’s New Outperform Rating Means for Investors
CoinCentral • Feb 25, 2026
Is AbbVie Stock Underperforming the Dow?
Yahoo Finance • Feb 24, 2026
RBC Capital Initiates Coverage on AbbVie (ABBV) with Outperform Rating | ABBV Stock News
GuruFocus • Feb 25, 2026
RBC Capital initiates Abbvie stock coverage with outperform rating
Investing.com • Feb 24, 2026
Is AbbVie Stock Underperforming the Dow?
Barchart.com • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for ABBV
Market Education
- Tax Loss Selling: A Strategic Way to Offset Gains Dec 10, 2024
- The Eagle’s Eye: Spotting Market Opportunities from Above Sep 8, 2025
- Finding Stocks in the Squeeze Zone: Using Finviz Jul 30, 2023
External Research